GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Dividend Payout Ratio

Consun Pharmaceutical Group (HKSE:01681) Dividend Payout Ratio : 0.25 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Dividend Payout Ratio?

Consun Pharmaceutical Group's dividend payout ratio for the months ended in Dec. 2023 was 0.25.

The historical rank and industry rank for Consun Pharmaceutical Group's Dividend Payout Ratio or its related term are showing as below:

HKSE:01681' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.27   Max: 4.71
Current: 0.42


During the past 12 years, the highest Dividend Payout Ratio of Consun Pharmaceutical Group was 4.71. The lowest was 0.11. And the median was 0.27.

HKSE:01681's Dividend Payout Ratio is ranked worse than
59.95% of 427 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs HKSE:01681: 0.42

As of today (2024-05-03), the Dividend Yield % of Consun Pharmaceutical Group is 7.53%.

During the past 12 years, the highest Trailing Annual Dividend Yield of Consun Pharmaceutical Group was 10.21%. The lowest was 0.67%. And the median was 2.82%.

Consun Pharmaceutical Group's Dividends per Share for the months ended in Dec. 2023 was HK$0.15.

During the past 12 months, Consun Pharmaceutical Group's average Dividends Per Share Growth Rate was 140.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 33.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 22.40% per year.

During the past 12 years, the highest 3-Year average Dividends Per Share Growth Rate of Consun Pharmaceutical Group was 48.20% per year. The lowest was -13.80% per year. And the median was 33.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Consun Pharmaceutical Group Dividend Payout Ratio Historical Data

The historical data trend for Consun Pharmaceutical Group's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Dividend Payout Ratio Chart

Consun Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.71 0.27 0.34 0.20 0.43

Consun Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.47 - 0.67 0.25

Competitive Comparison of Consun Pharmaceutical Group's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consun Pharmaceutical Group's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Dividend Payout Ratio falls into.



Consun Pharmaceutical Group Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Consun Pharmaceutical Group's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.456/ 1.073
=0.42

Consun Pharmaceutical Group's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0.152/ 0.617
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Consun Pharmaceutical Group (HKSE:01681) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Consun Pharmaceutical Group Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Consun Pharmaceutical Group (HKSE:01681) Business Description

Traded in Other Exchanges
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines